Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5644439 | Alergologia Polska - Polish Journal of Allergology | 2016 | 7 Pages |
Abstract
Omalizumab decreased the severity of symptoms, improved asthma control and quality of life in patients. It helped to reduce episodes of asthma exacerbation and the use of systemic corticosteroids. At present, the overall assessment by physicians is still the best and most reliable method of identifying responders to the omalizumab therapy.
Keywords
Related Topics
Life Sciences
Immunology and Microbiology
Immunology and Microbiology (General)
Authors
Agnieszka Gawlewicz-Mroczka, Weronika ZastrzeżyÅska, Marek Przybyszowski, Adam Ämiel, Krzysztof SÅadek,